When was Lunit founded?

Lunit was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is Lunit located?

Lunit is headquartered in Seoul, South Korea.

How many employees does Lunit have?

As of Mar 31, 2026, the latest employee count at Lunit is 357.

Is Lunit a funded company?

Lunit is a funded company, having raised a total of $135M across 7 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on 2014.

When was the latest funding round of Lunit?

Lunit's latest funding was a $***** Series C round on Nov 25, 2021, with participation from 5 investors.

Where does Lunit rank among its competitors?

Lunit ranks 2nd amongst 74 active competitors, of which 19 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Better Medicine, which secured $1.17M in Aug, 2025.

Who are the top competitors of Lunit?

Lunit's top competitors include Oxipit, Onc.ai and Median. Among them, Better Medicine secured the most recent funding round in August, 2025.

Lunit - 2026 Company Profile, Team, Funding & Competitors

Lunit is a public company based in Seoul (South Korea), founded in 2013 by Anthony Paek. It operates as a Developer of artificial intelligence solutions for cancer detection and treatment. Lunit has raised $135M in funding from investors like InterVest, Casdin Capital and Guardant Health. The company has 74 active competitors, including 19 funded and 6 that have exited. Its top competitors include companies like Oxipit, Onc.ai and Median.

Company Details

Developer of artificial intelligence solutions for cancer detection and treatment. The company’s technology supports early-stage cancer detection, enabling timely management and increased survival chances. It also provides artificial intelligence biomarkers for immunotherapy, predicting treatment response to increase efficacy. The company focuses on advancing precision oncology products.

Website: www.lunit.io/en/
Social

Key Metrics

Founded Year

2013

Location

Seoul, South Korea

Stage

Public

Total Funding

$135M in 7 rounds

Latest Funding Round

Series C, Nov 25, 2021, $*****

Investors

InterVest & 25 more

Ranked

2^nd among 74 active competitors

Employee Count

357 as on Mar 31, 2026

Investment & Acquisitions

Volpara Health

Similar Companies

Innovaccer & 2374 more

Exit Details

Public

View Lunit's full profile

Lunit got listed on Jul 21, 2022.

Click here to take a look at Lunit's IPO in detail

Lunit has raised a total funding of $135M over 7 rounds. Its first funding round was on 2014. Its latest funding round was a Series C round on Nov 25, 2021 for $*****. 5 investors participated in its latest round. Lunit has 26 institutional investors.

Here is the list of recent funding rounds of Lunit:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 25, 2021	9841509	Series C	1324440	5932625	2427861	9192857
Jul 19, 2021	9848997	Series C	1649195	1884296	4660139	Shinhan Financial Group & 5 more
Jan 06, 2020	4877403	Series C	2858456	6435975	Shinhan Investment Corp	Legend Capital & 5 more

Access funding benchmarks and valuations. Sign up today!

View details of Lunit's funding rounds and investors

The founders of Lunit is Anthony Paek.

Here are the details of Lunit's key team members:

Anthony Paek: Co-Founder of Lunit.
Contact Info: 1 email address

View details of Lunit's Founder profiles and Board Members

Lunit's employee count trend

Lunit has 357 employees as of Mar 26. Here is Lunit's employee count trend over the years:

Uncover Lunit's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Lunit include Oxipit, Onc.ai and Median. Here is the list of Top 10 competitors of Lunit, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Oxipit 2017, Vilnius (Lithuania), Acquired	Artificial intelligence based medical image analysis	$6.69M	Practica Capital, CoInvest Capital & 4 others	68/100
2nd	Lunit 2013, Seoul (South Korea), Public	Developer of artificial intelligence solutions for cancer detection and treatment	$135M	Formation 8, Tybourne Capital Management ... & 24 others	62/100
3rd	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Accomplice & 12 others	62/100
4th	Median 2002, Valbonne (France), Public	Provider of medical imaging software and services for clinical trials usage	$5.28M	Omega Funds, Auriga Partners & 6 others	58/100
5th	DeepWise 2017, Beijing (China), Series D	Developer of AI-based radiology image solutions primarily for cancer diagnosis	$115M	Legend Capital, CICC Capital & 14 others	57/100
6th	LPixel 2014, Tokyo (Japan), Series A	Image analysis tools using artificial intelligence	$7M	JAFCO Group, Mitsubishi UFJ Capital & 6 others	55/100
7th	Sycai Medical 2020, Barcelona (Spain), Seed	Provider of AI-based image diagnosis tool for healthcare professionals	$3.98M	Athos Capital, Bstartup Banco Sabadell & 5 others	54/100
8th	SimBioSys 2016, Chicago (United States), Series A	Provider of AI-based decision-making and cancer diagnosis tool for healthcare professionals	$20.2M	Northpond Ventures, Genoa Ventures & 4 others	54/100
9th	Koios Medical 2012, New York (United States), Series B	Provider of artificial intelligence based ultrasound to diagnose cancer	$15.9M	Mitsui, Bold Brain & 1 others	54/100
10th	Better Medicine 2020, Tartu (Estonia), Seed	AI-powered tools for radiologists to diagnose and fight cancer	$1.17M	Soulmates Ventures & 5 others	51/100